- Home
- PCF vs LFCR Comparison
PCF vs LFCR Comparison
Compare PCF & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCF
- LFCR
- Stock Information
- Founded
- PCF 1987
- LFCR 1986
- Country
- PCF United States
- LFCR United States
- Employees
- PCF N/A
- LFCR N/A
- Industry
- PCF Trusts Except Educational Religious and Charitable
- LFCR Biotechnology: Pharmaceutical Preparations
- Sector
- PCF Finance
- LFCR Health Care
- Exchange
- PCF Nasdaq
- LFCR Nasdaq
- Market Cap
- PCF 196.9M
- LFCR 164.3M
- IPO Year
- PCF N/A
- LFCR N/A
- Fundamental
- Price
- PCF $6.72
- LFCR $7.28
- Analyst Decision
- PCF
- LFCR Buy
- Analyst Count
- PCF 0
- LFCR 2
- Target Price
- PCF N/A
- LFCR $10.00
- AVG Volume (30 Days)
- PCF 74.8K
- LFCR 211.1K
- Earning Date
- PCF 01-01-0001
- LFCR 10-04-2024
- Dividend Yield
- PCF 10.90%
- LFCR N/A
- EPS Growth
- PCF N/A
- LFCR N/A
- EPS
- PCF N/A
- LFCR 0.17
- Revenue
- PCF N/A
- LFCR $128,443,999.00
- Revenue This Year
- PCF N/A
- LFCR $2.23
- Revenue Next Year
- PCF N/A
- LFCR $8.40
- P/E Ratio
- PCF N/A
- LFCR $50.94
- Revenue Growth
- PCF N/A
- LFCR 23.42
- 52 Week Low
- PCF $5.71
- LFCR $3.68
- 52 Week High
- PCF $6.96
- LFCR $8.90
- Technical
- Relative Strength Index (RSI)
- PCF 45.51
- LFCR 61.28
- Support Level
- PCF $6.70
- LFCR $6.27
- Resistance Level
- PCF $6.84
- LFCR $7.23
- Average True Range (ATR)
- PCF 0.06
- LFCR 0.46
- MACD
- PCF -0.01
- LFCR 0.04
- Stochastic Oscillator
- PCF 20.00
- LFCR 53.88
About PCF High Income Securities Fund
High Income Securities Fund is a closed-end management investment company. Its primary objective is to provide high current income and capital appreciation is the secondary objective. The Fund pursues its objective primarily by investing in both convertible bonds and convertible preferred stocks. The Fund also invests significantly in high-yielding non-convertible securities with the potential for capital appreciation.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.